Related Experiment Video
Updated: Sep 29, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Neuroimmune communication regulating pruritus in atopic dermatitis
Martin Steinhoff1, Fareed Ahmad2, Atul Pandey2
1Department of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Department of Dermatology, Weill Cornell Medicine-Qatar, Doha, Qatar; Qatar University, College of Medicine, Doha, Qatar; Department of Dermatology, Weill Cornell Medicine, New York, NY.
Atopic dermatitis (AD) involves complex neuroimmune interactions, where nerve signaling exacerbates skin inflammation and itch. Targeting these neuroimmune circuits offers a promising therapeutic strategy for managing AD symptoms.
Area of Science:
- Dermatology
- Neuroscience
- Immunology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition with a substantial disease burden.
- AD pathogenesis involves the interplay between the nervous and immune systems, leading to inflammation, itch, pain, and skin barrier defects.
Purpose of the Study:
- To elucidate the role of neuroimmune circuits in the pathophysiology of atopic dermatitis.
- To explore the potential of targeting neuroimmune pathways for therapeutic interventions in AD.
Main Methods:
- Review and synthesis of current understanding of neuroimmune signaling in AD.
- Analysis of how sensory nerve activation and neuromediator release contribute to AD pathology.
Main Results:
- Dysregulation of neuroimmune circuits is central to AD, driving inflammation, pruritus, and barrier dysfunction.
- Sensory nerve activation triggers itch and releases mediators that worsen inflammation and skin barrier issues.
- Neuronal dysfunction contributes to neuroinflammation, sensitization, and neuropathic itch, leading to chronification and treatment resistance.
Conclusions:
- Neuroimmune circuits in both the skin and central nervous system are viable therapeutic targets for managing pruritus in AD.
- Targeted therapies, including pathway inhibitors, hold potential for controlling AD symptoms by addressing neuroimmune dysregulation.
Related Concept Videos
Sensory Functions of the Skin
There are two main categories of receptors on the skin: capsulated and non-capsulated. The non-capsulated ones are mainly the pain receptors. The capsulated ones can be further categorized based on the...
Nociception
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

